BIT Analytical Acquires C2 Diagnostics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BIT Analytical Instruments has acquired French OEM diagnostics instruments firm C2 Diagnostics for an undisclosed sum.

Schwalbach, Germany-based BIT said that the deal will enable it to offer a larger range of services and technologies offered in the areas of clinical chemistry, immunology, and molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.